Efficacy of Oral Ibandronate in Osteoporosis

Shinshu University

Status and phase: Enrolling; Phase 2

Conditions: Osteoporosis

Treatments: Drug: Oral Ibandronate and Vitamin D; Drug: Ibandronate

Study type: Interventional

Funder types: Other

Identifiers

NCT03186131

Oral IBN2017

Details and patient eligibility

About

There has been no comparative data between oral ibandronate and oral ibandronate plus active vitamin D

Enrollment: 100 estimated patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Osteoporotic patients who want to take oral ibandronate

Exclusion criteria

• Patients who are allergic to oral ibandronate or vitamin D Patients who have not taken oral ibandronate for the last 2 years

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

100 participants in 2 patient groups

Oral Ibandronate alone

Active Comparator group

Description:

Monthly Oral Intake of Ibandronate

Treatment:

Drug: Ibandronate

Oral Ibandronate and Vitamin D

Active Comparator group

Description:

Monthly oral intake of Ibandronate and daily oral intake of Vitamin D

Treatment:

Drug: Oral Ibandronate and Vitamin D